120 related articles for article (PubMed ID: 7718254)
1. The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma.
Steinbeck RG; Heselmeyer KM; Moberger HB; Auer GU
Acta Oncol; 1995; 34(2):171-6. PubMed ID: 7718254
[TBL] [Abstract][Full Text] [Related]
2. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions.
Maeda MY; Simões M; Wakamatsu A; Longatto Filho AL; Oyafuso M; de Mello ES; Otta MM; Alves VA
Pathologica; 2001 Jun; 93(3):189-95. PubMed ID: 11433611
[TBL] [Abstract][Full Text] [Related]
3. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
6. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.
Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG
Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365
[TBL] [Abstract][Full Text] [Related]
10. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
12. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression.
Hirano T; Franzén B; Kato H; Ebihara Y; Auer G
Am J Pathol; 1994 Feb; 144(2):296-302. PubMed ID: 7906095
[TBL] [Abstract][Full Text] [Related]
13. Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis.
Steinbeck RG
Acta Oncol; 1997; 36(1):3-12. PubMed ID: 9090961
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.
Herbsleb M; Knudsen UB; Orntoft TF; Bichel P; Norrild B; Knudsen A; Mogensen O
APMIS; 2001 Sep; 109(9):607-17. PubMed ID: 11878714
[TBL] [Abstract][Full Text] [Related]
15. p53, Bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis.
Astudillo H; Lopez T; Castillo S; Gariglio P; Benitez L
Ann N Y Acad Sci; 2003 Dec; 1010():771-4. PubMed ID: 15033825
[No Abstract] [Full Text] [Related]
16. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
17. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
Wang LD; Shi ST; Zhou Q; Goldstein S; Hong JY; Shao P; Qiu SL; Yang CS
Int J Cancer; 1994 Nov; 59(4):514-9. PubMed ID: 7960222
[TBL] [Abstract][Full Text] [Related]
18. DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions.
Steinbeck RG; Moege J; Heselmeyer KM; Klebe W; Neugebauer W; Borg B; Auer GU
Eur J Cancer B Oral Oncol; 1993 Oct; 29B(4):279-84. PubMed ID: 11706421
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri.
Cardillo MR; Stamp GW; Pignatelli MN; Lalani EN
Eur J Gynaecol Oncol; 1993; 14(6):484-90. PubMed ID: 7910135
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]